Clinical Trial Update: Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine plus bevacizumab in locally recurrent or metastatic breast cancer has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Gemzar (gemcitabine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Metastatic Breast Cancer, Locally Advanced Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-01-09